Summary:
Click image to enlargeThis study is designed to rigorously assess the efficacy of a new injection treatment for common warts, which are caused by the human papillomavirus (HPV) and can be persistent and bothersome for many individuals.
Qualified Participants Must:
• 12 years old or older
•
Have 3-20 common warts (excluding palms, toes, and soles of feet)
Qualified Participants May Receive:
Qualified participants may receive:
- Compensation up to $3,400
- Study-Related Medication at no cost to you or your insurance
- Free medical care